Northwire Canada EditionSaturday, July 11, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%

← Back to our analysis

Original News Release

Healwell AI to release 2025 results March 19

Mr. James Lee reports HEALWELL AI TO ANNOUNCE FOURTH QUARTER AND YEAR END 2025 FINANCIAL RESULTS ON MARCH 19, 2026 Healwell AI Inc. will release its fiscal fourth quarter and year-end 2025 financial results for the period ended Dec. 31, 2025, on Thursday, March 19, 2026. The company will hold a conference call and simultaneous webcast to discuss its results on the following day, Friday, March 20, 2026, at 8:30 a.m. ET (5:30 a.m. PT). The call will be hosted by James Lee, chief executive officer, Dr. Alexander Dobranowski, president, and Anthony Lam, chief financial officer. Healwell AI fourth quarter and year-end 2025 financial results conference call Date:  Friday, March 20, 2026 Time:  8:30 a.m. ET/5:30 a.m. PT Toll-free North America:  1-800-715-9871 Toronto local and international toll:  1-647-932-3411 When connecting to the conference call by phone, please dial in 10 minutes prior to the start of the call and ask to be joined into the Healwell AI conference call. About Healwell AI Inc. Healwell is a health care artificial intelligence company focused on preventive care. Its mission is to improve health care and save lives through early identification and detection of disease. Using its own proprietary technology, the company is developing and commercializing advanced clinical decision support systems that can help health care providers detect rare and chronic diseases, improve efficiency of their practices, and ultimately help improve patient health outcomes. Healwell is executing a strategy centred on developing and acquiring technology and clinical sciences capabilities that complement the company's road map. Healwell is publicly traded on the Toronto Stock Exchange under the symbol AIDX and on the OTC (over-the-counter) exchange under the symbol HWAIF.
View at source ↗